Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
Jinhong Shi, Feiqi Liu, Yanqiu Song Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, People’s Republic of ChinaCorrespondence: Yanqiu SongThe First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin 130021, People’s Republic of ChinaTel +...
Main Authors: | Shi J, Liu F, Song Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/progress-targeted-therapy-immunotherapy-and-new-chemotherapy-strategie-peer-reviewed-article-CMAR |
Similar Items
-
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
by: Ruoning Yang, et al.
Published: (2022-03-01) -
Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021-11-01) -
Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
by: Hyungjoo Kim, et al.
Published: (2022-05-01) -
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
by: Ashley Schreier, et al.
Published: (2023-01-01) -
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
by: Claudia Trojaniello, et al.
Published: (2021-06-01)